Quantcast
Last updated on April 19, 2014 at 8:32 EDT

Latest Sudafed Stories

2014-02-18 16:26:46

WASHINGTON, Feb. 18, 2014 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) today released the following statement after the West Virginia State Senate passed Senate Bill 6--legislation that would require all citizens to obtain a doctor's prescription before buying safe and effective cold and allergy medicines containing pseudoephedrine (PSE)--medicines like Advil Cold & Sinus, Claritin-D, Mucinex D and Sudafed. The bill now heads to the House of Delegates for...

2013-07-25 23:00:50

Pregnant women who use nasal decongestants during the first trimester may be raising the risk that their newborn will suffer from one or more rare birth defects, according to a Reuters report about a new study. National law firm Parker Waichman LLP is now evaluating legal claims. New York, New York (PRWEB) July 25, 2013 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, notes that women who use nasal decongestants during the...

2013-06-13 12:29:29

Repeat Brand of the Year Awards For TUMS, Vicks, FiberCon, Tylenol PM and Walgreens; Dulcolax and Tylenol Pain Reliever are at the top of their respective categories for the first time NEW YORK, June 13, 2013 /PRNewswire/ -- The rise of medical and health information websites has led to an increased number of consumers accessing unlimited quantities of information, studies and diagnoses. This growth of health-focused websites has created competition, with some well-known brands...

2012-12-20 08:27:17

PISGAH FOREST, N.C., Dec. 20, 2012 /PRNewswire/ -- Pisgah Laboratories, Inc. (www.Pisgahlabs.com), an innovative pharmaceutical development company located in Western North Carolina, may have some relief for those who regularly fall victim to the cough, cold and allergy season. Pisgah recently received US Patent 8,334,322 from the United States Patent and Trademark Office (www.uspto.gov) for innovative, abuse-deterrent forms of pseudoephedrine and ephedrine. The issued patent was for their...

2012-04-09 06:24:14

WASHINGTON, April 9, 2012 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) today applauded Idaho Governor C.L. "Butch" Otter for signing into law real-time, stop-sale technology called the National Precursor Log Exchange (NPLEx) which allows check-out clerks to block illegal pseudoephedrine purchases right at the point of sale and provides law enforcement with valuable criminal data up to the minute. The legislation--Senate Bill 1309--was sponsored by Senator Joyce M....

2012-03-13 13:35:00

WASHINGTON, March 13, 2012 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) today applauded the West Virginia Legislature for passing legislation requiring real-time, stop-sale technology to enable pharmacists to block illegal pseudoephedrine purchases right at the point of sale and provide law enforcement with valuable criminal data up to the minute. The legislation--Senate Bill 437--was authored by Governor Earl Ray Tomblin and sponsored by Senate President Jeffery...

2012-03-09 13:15:00

WASHINGTON, March 9, 2012 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) today applauded the Commonwealth of Virginia for becoming the 18th state to adopt real-time, stop-sale technology called the National Precursor Log Exchange (NPLEx) which allows pharmacists to block illegal pseudoephedrine purchases right at the point of sale and provides law enforcement with valuable criminal data up to the minute. The legislation, sponsored by Senator L. Louise Lucas (D- District...

2012-03-07 14:37:00

WASHINGTON, March 7, 2012 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) today released the following statement after the Alabama House Health Committee unanimously passed House Bill 363, legislation authored by Representative Blaine Galliher that tackles methamphetamine production in Alabama by making smurfing a felony offense, implementing reasonable reductions to pseudoephedrine (PSE) purchasing limits, and activating a statewide drug offender...

2012-03-06 11:13:00

WASHINGTON, March 6, 2012 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) released today a recent poll that found a majority of Missourians -- by a margin of 16 percent -- continue to favor nonprescription access to safe and effective medicines containing pseudoephedrine (PSE), such as Advil Cold & Sinus, Allegra-D, Claritin-D, Mucinex-D, and Sudafed over a prescription mandate. The poll also found that more than three out of four Missourians (78%) said they agreed...

2012-03-01 12:37:00

WASHINGTON, March 1, 2012 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) released the following statement after the Kentucky Senate Judiciary Committee passed Senate Bill 3, legislation that would impose significant restrictions on safe and effective medicines containing pseudoephedrine (PSE), such as Advil Cold & Sinus, Allegra-D, Claritin-D, Mucinex D, and Sudafed. SB 3 would limit the amount of PSE consumers can buy to 15 grams a year and 3.6 grams a month. The...